EOI

AG&P LNG and Hai Linh Announce the Start of the Commissioning of their Cai Mep LNG Terminal in Vietnam

Retrieved on: 
Mercredi, mai 8, 2024

HANOI, Vietnam, May 8, 2024 /PRNewswire/ -- Leading LNG terminals and downstream infrastructure company, AG&P LNG, a subsidiary of Nebula Energy, along with its partner, Hai Linh Company Limited, a prominent petroleum product import terminal and trader, in Vietnam today announced the start of the commissioning of the Cai Mep LNG Terminal in an elaborate 'Cai Mep LNG Terminal Commissioning Symposium' hosted at the terminal. 

Key Points: 
  • Cai Mep LNG Terminal will provide integrated LNG supply solution through AG&P LNG and Hai Linh downstream joint venture – Vietfirst Gas.
  • The 3 MTPA Cai Mep LNG Terminal, expandable to 6 MTPA, is one of only two existing LNG terminals located in Vietnam.
  • HANOI, Vietnam, May 8, 2024 /PRNewswire/ -- Leading LNG terminals and downstream infrastructure company, AG&P LNG, a subsidiary of Nebula Energy, along with its partner, Hai Linh Company Limited, a prominent petroleum product import terminal and trader, in Vietnam today announced the start of the commissioning of the Cai Mep LNG Terminal in an elaborate 'Cai Mep LNG Terminal Commissioning Symposium' hosted at the terminal.
  • Le Van Tam, CEO, Hai Linh Company Limited, said, "I am excited to announce the commissioning of our Cai Mep LNG Terminal.

Unibail-Rodamco-Westfield Airports and The New Terminal One Launch the Competitive Evaluation Process for Food Hall, Travel Essentials Partners

Retrieved on: 
Jeudi, mai 2, 2024

NEW YORK, May 2, 2024 /PRNewswire/ -- Unibail-Rodamco-Westfield (URW) Airports and The New Terminal One (NTO) announced today the Competitive Evaluation Process (CEP) for the Food Hall and Travel Essentials tenders, marking another significant milestone in the development of the commercial program for the privately funded all-international terminal.

Key Points: 
  • NEW YORK, May 2, 2024 /PRNewswire/ -- Unibail-Rodamco-Westfield (URW) Airports and The New Terminal One (NTO) announced today the Competitive Evaluation Process (CEP) for the Food Hall and Travel Essentials tenders, marking another significant milestone in the development of the commercial program for the privately funded all-international terminal.
  • Structured as a single package of one landside and five airside units totaling 3,736 square-feet, the tender will cover approximately half of the Food Hall in The New Terminal One.
  • Both the Food Hall and Travel Essentials tenders require bidders to propose a minimum of 30% ACDBE participation.
  • Click here to join our list and stay up to date on news and events about the NTO commercial program.

Pacific Life and Selerix Elevate Benefits Administration with Real-Time Integration

Retrieved on: 
Jeudi, avril 25, 2024

Pacific Life’s Workforce Benefits business today announced its integration with Selerix, a comprehensive benefits administration platform.

Key Points: 
  • Pacific Life’s Workforce Benefits business today announced its integration with Selerix, a comprehensive benefits administration platform.
  • “We are excited to join Selerix and elevate the experience for all stakeholders.”
    Key advantages of the Pacific Life and Selerix integration:
    Real-Time Updates: Benefit changes are reflected instantly, minimizing delays and ensuring accurate information.
  • “Pacific Life’s tech-forward approach aligns perfectly with our vision.”
    Pacific Life’s Workforce Benefits business offers dental, vision, and group term life with accidental death and dismemberment (AD&D).
  • To learn more about how Pacific Life is revolutionizing employee benefits with a friction-free, digitally native experience, visit www.pacificlife.com/workforcebenefits .

PROTEIN INDUSTRIES CANADA OPENS CALL FOR TECHNOLOGY LEADERSHIP PROJECTS

Retrieved on: 
Mardi, avril 2, 2024

Regina, SK, April 02, 2024 (GLOBE NEWSWIRE) -- Protein Industries Canada is opening their third call for proposals under their Technology Leadership Project program stream.

Key Points: 
  • Regina, SK, April 02, 2024 (GLOBE NEWSWIRE) -- Protein Industries Canada is opening their third call for proposals under their Technology Leadership Project program stream.
  • In addition to opening the third all for Technology Leadership Projects, Protein Industries Canada is also moving to a continual intake for projects under the Pan-Canadian Artificial Intelligence Program Stream (PCAIS).
  • This is Protein Industries Canada’s third call for Technology Leadership Projects since being recapitalized by the federal government in February 2023.
  • Through the first two calls for projects, more than $70 million has been committed into 16 Technology Leadership projects.

Reliance Matrix Announces Integration With bswift®

Retrieved on: 
Mercredi, avril 3, 2024

The Reliance Matrix integration is available to bswift clients and through channel partner programs.

Key Points: 
  • The Reliance Matrix integration is available to bswift clients and through channel partner programs.
  • The integration leverages Reliance Matrix’s proprietary Matrixlink® technology, a purpose built data integration platform designed to transform and integrate employer and employee data through modern connections.
  • Highlights of the bswift integration include:
    Direct Billing from bswift Data: Quickly generate accurate Reliance Matrix invoices directly from bswift, without manual reconciliation or EDI uploads.
  • For more information, contact your Reliance Matrix sales or account manager, or visit Reliance Matrix on the bswift platform.

PlanSource’s 2024 Product Release Bring Benefits Engagement and AI to the Forefront

Retrieved on: 
Jeudi, février 1, 2024

ORLANDO, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- PlanSource , a leading provider of cloud-based benefits administration technology, announced today the launch of its Winter 2024 Product Release.

Key Points: 
  • ORLANDO, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- PlanSource , a leading provider of cloud-based benefits administration technology, announced today the launch of its Winter 2024 Product Release.
  • The Source , a benefits engagement platform, which consolidates benefits enrollment and utilization into a single mobile-friendly experience, adds exciting new features.
  • In this release, PlanSource has unveiled Olive, a new AI assistant, who is ready to create tailored communications for HR teams.
  • In 2024, PlanSource will invest heavily in streamlining the platform for HR teams through AI, seamless integrations, and functionality to simplify the HR administrators' day-to-day.

Reliance Matrix Launches First-of-its-Kind Integration with PlanSource

Retrieved on: 
Mardi, janvier 30, 2024

The enhanced integration marks an unmatched level of ease and accuracy for benefits enrollment and administration on the PlanSource platform.

Key Points: 
  • The enhanced integration marks an unmatched level of ease and accuracy for benefits enrollment and administration on the PlanSource platform.
  • “Our partnership with PlanSource began in earnest in 2021 when we joined the Boost program and delivered preferred pricing and a smooth, intuitive enrollment experience to our mutual clients,” said Kevin McPhillips, AVP of Platform Partnership Integration for Reliance Matrix.
  • In contrast, the EOI Submission API, a unique end-point developed by Reliance Matrix, seamlessly integrates all medical and state required questions directly in PlanSource, automating all authentication behind the scenes.
  • For more information, contact your Reliance Matrix sales or account manager, or visit Reliance Matrix on the PlanSource platform.

ITRI's CES 2024 Showcase Leads Tech Trends, Highlighting Global Collaborations

Retrieved on: 
Vendredi, janvier 12, 2024

HSINCHU, Jan. 11, 2024 /PRNewswire/ -- At CES 2024, ITRI presented ten groundbreaking innovations spanning AI robotics, smart sports, digital health, and AI display and entertainment.

Key Points: 
  • HSINCHU, Jan. 11, 2024 /PRNewswire/ -- At CES 2024, ITRI presented ten groundbreaking innovations spanning AI robotics, smart sports, digital health, and AI display and entertainment.
  • The CES 2024 trends were predicted to be AI, sustainability, and inclusivity.
  • Through CES, ITRI is opening up even more collaboration opportunities, engaging with potential investors, and exploring tech licensing and ventures."
  • Notably, iGolfPutter has been named by Forbes Magazine as one of the technologies to look for at CES 2024.

ITRI's Showcase at CES 2024 Highlights AI, Sustainability, and Inclusivity, Earns Praise from CTA

Retrieved on: 
Mercredi, janvier 10, 2024

Director of Market Research at the Consumer Technology Association (CTA), Jessica Boothe, praised ITRI's exhibits for embodying the CES 2024 trends of AI, sustainability, and inclusivity.

Key Points: 
  • Director of Market Research at the Consumer Technology Association (CTA), Jessica Boothe, praised ITRI's exhibits for embodying the CES 2024 trends of AI, sustainability, and inclusivity.
  • The CES 2024 trends were predicted to be AI, sustainability, and inclusivity.
  • Through CES, ITRI is opening up even more collaboration opportunities, engaging with potential investors, and exploring tech licensing and ventures."
  • Notably, iGolfPutter has been named by Forbes Magazine as one of the technologies to look for at CES 2024.

Y-mAbs Announces Publication in Cancers

Retrieved on: 
Lundi, octobre 16, 2023

“The publication in Cancers further validates the utilization of naxitamab early during the course of treatment for patients with high-risk neuroblastoma,” said Thomas Gad, Founder, President and Interim Chief Executive Officer.

Key Points: 
  • “The publication in Cancers further validates the utilization of naxitamab early during the course of treatment for patients with high-risk neuroblastoma,” said Thomas Gad, Founder, President and Interim Chief Executive Officer.
  • Cycles were administered 3-5 weeks apart and the primary endpoint was overall response rate (CR + partial response (“PR”)).
  • The HITS combination did not appear to exacerbate the rate nor the intensity of infusion-related toxicities of naxitamab when observed as a stand-alone treatment.
  • Researchers at Memorial Sloan Kettering Cancer Center (MSK) developed DANYELZA® (naxitamab-gqgk), which is exclusively licensed by MSK to Y-mAbs.